• Home

  • About

  • All News

  • Press Releases

  • Network

  • More

    Use tab to navigate through the menu items.
    • LinkedIn

    District 


    Driven by

    Intelligence™
    biotech brothers

    • All Posts
    • News
    • Pharma
    • Opinion
    • Money
    • Intelligence
    • Marketing
    Search
    Taiwan Biotech PharmaEssentia Gets FDA Approval for Rare Blood Disease
    Staff
    • Nov 19, 2021
    • 2 min

    Taiwan Biotech PharmaEssentia Gets FDA Approval for Rare Blood Disease

    The U.S. Food and Drug Administration last Friday granted approval for Besremi (ropeginterferon alfa-2b-njft) injection for treatments of...
    Johnson and Johnson Breaksup with Consumer Health Unit 💔
    Staff
    • Nov 17, 2021
    • 2 min

    Johnson and Johnson Breaksup with Consumer Health Unit 💔

    Johnson & Johnson said it plans to spin off its consumer health unit that markets Baby Powder and Listerine to concentrate on...
    Top 5 Biotech Stocks on Reddit October Edition
    Staff
    • Oct 20, 2021
    • 2 min

    Top 5 Biotech Stocks on Reddit October Edition

    Biotech is one of the most expensive industries in the world, and prospectively it will keep advancing as the world knows new age of...
    Merck Applies EUA for  Antiviral Molnupiravir
    Staff
    • Oct 11, 2021
    • 3 min

    Merck Applies EUA for Antiviral Molnupiravir

    Merck (NYSE: MRK) referred to as MSD outside U.S. and Canada, and Ridgeback Biotherapeutics last Friday made it known that Molnupiravir...
    AI Startup Exscientia Gets $304.7 Million Upsizing of Initial Public Offering 💸📈
    Staff
    • Oct 9, 2021
    • 2 min

    AI Startup Exscientia Gets $304.7 Million Upsizing of Initial Public Offering 💸📈

    Exscientia plc, an Artificial Intelligence firm focused on discovering, designing and developing the highest quality medications in the...
    Pharmaceutical Blockbusters to Lookout For 💸
    Staff
    • Sep 22, 2021
    • 3 min

    Pharmaceutical Blockbusters to Lookout For 💸

    2021 has already witnessed many eventful FDA approvals. Not even the pandemic could stop biopharma’s historic ability to push prospects...
    Takeda’s EXKIVITY Gets FDA Greenlight For Non-Small Cell Lung Cancer
    Staff
    • Sep 18, 2021
    • 2 min

    Takeda’s EXKIVITY Gets FDA Greenlight For Non-Small Cell Lung Cancer

    Osaka-based pharma, Takeda Pharmaceutical Company Limited (“Takeda”) on Wednesday announced the U.S. Food and Drug Administration (FDA)’s...
    Replicate Bioscience Liftoffs with $40 Million in Series A Funding to Develop srRNA Technology
    Staff
    • Sep 11, 2021
    • 3 min

    Replicate Bioscience Liftoffs with $40 Million in Series A Funding to Develop srRNA Technology

    Life sciences venture firm TP on Wednesday announced the launch of Replicate Bioscience in a bid to replicating the success RNA...
    Biotech Fraud Elizabeth Holmes Starts Trial for Theranos Scheme
    Staff
    • Sep 10, 2021
    • 2 min

    Biotech Fraud Elizabeth Holmes Starts Trial for Theranos Scheme

    The trial of the founder of Theranos, Elizabeth Holmes began on Wednesday in federal court in San Jose, California. Elizabeth who dropped...
    Renovorx Files Initial Public Offering
    Staff
    • Aug 19, 2021
    • 2 min

    Renovorx Files Initial Public Offering

    California-based RenovoRx, Inc. (NASDAQ: RNXT) has filed for offering up to 1.85 million units of securities in an initial public...
    FDA Approves Nexviazyme For Pompe Disease
    Staff
    • Aug 8, 2021
    • 2 min

    FDA Approves Nexviazyme For Pompe Disease

    On August 6, 2021, the U.S. Food and Drug Administration announced it has approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous...
    Amgen Acquires Teneobio For $900 Million
    Staff
    • Aug 6, 2021
    • 3 min

    Amgen Acquires Teneobio For $900 Million

    Amgen and Teneobio on July 27, 2021 announced they had reached an agreement which will see Amgen acquire Teneobio, a privately held,...
    U.S. SEC Mandates Chinese IPO Hopefuls to Provide Additional Risk Disclosures
    Staff
    • Aug 1, 2021
    • 3 min

    U.S. SEC Mandates Chinese IPO Hopefuls to Provide Additional Risk Disclosures

    The U.S. securities regulator in an exclusive report released on July 30 says it will not allow Chinese companies to undertake...
    ICER Rejects Aduhelm’s Benefits to Patients
    Staff
    • Jul 24, 2021
    • 3 min

    ICER Rejects Aduhelm’s Benefits to Patients

    Is there ample proof that Biogen’s new Alzheimer’s med Aduhelm is beneficial to patients, physicians and society beyond the existing...
    Press Release: European Medicines Agency Grants Orphan Drug Designation to Zydus for PBC
    Staff
    • Jul 22, 2021
    • 2 min

    Press Release: European Medicines Agency Grants Orphan Drug Designation to Zydus for PBC

    European Medicines Agency grants Orphan Drug Designation to Saroglitazar Mg for the treatment of patients with Primary Biliary...
    Jazz Pharmaceuticals Launches Educational Site for Small Cell Lung Cancer
    Staff
    • Jul 5, 2021
    • 2 min

    Jazz Pharmaceuticals Launches Educational Site for Small Cell Lung Cancer

    Understanding there’s nothing small about a small cell lung cancer diagnosis, Jazz Pharmaceuticals is collaborating with four major lung...
    Is Elon Musk's startup Neuralink the Future of Tech in Healthcare?
    Staff
    • Jul 4, 2021
    • 3 min

    Is Elon Musk's startup Neuralink the Future of Tech in Healthcare?

    Have you ever imagined the possibility of using your smartphone with your brain? Like, being able to operate your device with your mind,...
    Alzheimer’s Association Slams Biogen’s $56K Aduhelm List Price
    Staff
    • Jun 19, 2021
    • 2 min

    Alzheimer’s Association Slams Biogen’s $56K Aduhelm List Price

    Biogen’s decision to price its historic Alzheimer’s med Aduhelm at a mouthwatering $56,000 per year expectedly vexed lawmakers in...
    Novo’s Semaglutide Won its Coveted FDA Green Light to Treat Obesity
    Staff
    • Jun 13, 2021
    • 2 min

    Novo’s Semaglutide Won its Coveted FDA Green Light to Treat Obesity

    With obesity prevalent, undertreated, and hugely misunderstood, Novo Nordisk has been attempting to revolutionize the field with...
    FDA Approves Lumakras For Non-Small Lung Cancer
    Staff
    • Jun 11, 2021
    • 3 min

    FDA Approves Lumakras For Non-Small Lung Cancer

    The U.S. Food and Drug Administration on May 28, 2021 approved Lumakras (Sotorasib) as the first therapy for adult patients with...
    1
    2345

    Back to Top

    Subscribe to Our Newsletter

    Thanks for submitting!

    • Home
    • About
    • All News
    • Press Releases
    • Network

    Support Journalism
     

    • White Facebook Icon

    © 2020 by BiotechDistrict Subsidiary of Biotech Brothers LLC. Proudly Independent.